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Abstract

The study investigates the nutritional status of patients receiving
radiotherapy for treatment of cancer in an outpatient setting. There were
39 subjects who were divided into four study groups depending on the
positon of their treatment field. Three patients received treatment to the
head and neck area (HN), 17 patients were receiving abdomino-pelvic
irradiation (AP), 15 received radiotherapy to the chest (C) and five
received treatment to parts of the body not associated with the
gastrointestinal tract (O). Anthropometric, clinical and dietary indicators
of nutritional status were used, these included measurements of Body
Mass Index and weight loss, a subjective questionnaire in which patients
reported possible nutrition compromising side effects of treatment and a
24 hour dietary recall to estimate energy and protein intakes before and
after treatment.

The anthropometric and dietary indicators altered little with treatment
and did not indicate a change in nutritional status. The clinical indicators
were most important in detecting changes in the nutritional status of the
patients.

Clinical indications of declining nutritional status differed

between the study groups.

The AP group was found to be likely to

develop diarrhoea during the course of radiotherapy. The C group was
found to be at high risk of developing dysphagia during treatment. The
HN group was expected to suffer the most changes in clinical indicators
such as anorexia, xerostomia, dysphagia and dysgeusia, however, the
number of patients in the group was too small to draw any meaningful
results. The study recommends that a number of indicators of nutritional
status, including

anthropometric, biochemical, clinical

and

dietary

indicators should be used when assessing the nutritional status of cancer
patients.
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Chapter 1

Introduction

Chapter 1
Introduction

Background and Statement of the Problem

In July, 1993, the newly opened Cancer Care Centre (CCC) at The St
George

Hospital,

Kogarah,

began

treating

its

first

radiotherapy

outpatients. The CCC had employed a number of full time Allied Health
staff including 1.5 Full Time Equivalent (FTE) Dietitians. The number of
outpatients receiving radiotherapy was expected to be high (up to 85 per
day) and a significant proportion of these patients were expected to
encounter nutrition related problems as a consequence of the treatment. It
was therefore believed that a screening mechanism would need to be
developed and used, thereby enabling the Dietitians in the CCC to more
efficiently

identify, prioritise

and treat those nutritionally

at-risk

individuals.

This study was developed to describe the nutritional status of the
outpatients prior to radiotherapy commencing and to describe the changes
in nutritional status as the therapy progressed.
nutritional

status

of

the

outpatients

would

Information about the
be

anthropometric, subjective and dietary measures.

gathered

using

Comparisons of

nutritional status between groups of patients with different cancer types
and treatment sites would be made. It was hoped that this information
could be used to develop parameters for screening patients to identify
potential nutritional problems before therapy commenced.

This was

expected to achieve minimisation of the impact of radiotherapy on the
patient's nutritional status.

Definition of Terms

'Cachexia' from the Greek words kakos, meaning 'bad' and hexis, meaning
'condition'.

A syndrome in which patients with malignant disease

develop anorexia, weakness and severe weight loss which greatly
contributes to the morbidity and mortality of such patients.

'Radiotherapy' The use of radiation (such as x-rays) in the treatment of
Cancer and other diseases.

'Gray' The SI unit of absorbed radiation dose, equal to the transfer of 1
joule of energy per kilogram of absorbing material.

'Fraction' The total radiation dose administered to a patient is divided
into smaller doses called fractions.

Chapter 2
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Chapter 2
Literature Review

2.1 Introduction

The term 'cancer' encompasses a group of neoplastic disorders which are
characterised by transformation of normal cells into malignant ones.
There is often a marked decline in the nutritional status of patients with
cancer (Torosian and Daly, 1986). This deterioration in nutritional status
can be caused by the disease itself, the effects of the treatment of the
disease or a combination of these factors (Donaldson and Lenon, 1979).
The most common treatments for cancer are surgery, chemotherapy and
radiotherapy, all of which can have an impact on the patient's nutritional
status (Kokal, 1985). This project is concerned with how radiotherapy
treatment affects the nutritional status of cancer patients.

2.2 Cancer Cachexia

Cancer cachexia is a syndrome which is characterised by anorexia, severe
weight loss, tissue wasting, early satiety and weakness.

Cachexia is

driven by the presence of a tumour and the effects of cachexia are
reversed by removal of the tumour (Norton, et al., 1985). In 1932, Warren
noticed a relationship between wasting and mortality in postmortem
examinations of cancer patients. He concluded that cachexia was the most
frequent single cause of death in cancer patients. Kern and Norton (1988),
concluded that most cancer patients have clinically detectable cachexia.
This is supported by Nixon et. al. (1980) who found widespread protein
energy malnutrition (PEM) in cancer patients based on creatinine-height
ratio.

It is unclear whether the weight loss associated with cachexia is due to
decreased caloric intake, increased energy requirements or a combination
of the two. Numerous factors can be identified that may lead to anorexia
and decreased caloric intake in oncology patients. These include intestinal
obstruction or fistula formation, radiotherapy or chemotherapy induced
nausea, vomiting, altered taste sensations, mucosal damage or anxiety
(Fearon and Carter, 1988).

Very few attempts have been made to

accurately describe the energy and protein intakes of oncology patients.
Holroyde and Reichard (1986) believe this is because of the limitations of
retrospective dietary analysis and patient recall. They report that daily
caloric intakes in groups of adult weight losing oncology patients have
ranged from 4800-6500kJ in various studies.

Unfortunately, the

nutritional requirements of cancer patients are as yet unknown and hence
any estimations of energy or protein intakes may only be compared to
requirements for populations without cancer.

Another possible reason for the weight loss seen in cachexia is an
increased energy expenditure. Some studies (Lindmark et al, 1984) have
shown increases in energy expenditure in oncology patients of 5-20%,
others (Knox et al, 1983) have shown that some cancer patients are
hypermetabolic (26%), some are hypometabolic (33%) and some have
normal rates of metabolism (41%), still other studies have shown no
difference between energy expenditure rates of cancer patients when
compared to controls (Hansell et al., 1986). Clearly, more research needs
to be done in this area, however it seems that cancer may have a marked
effect on the host's metabolism and this may lead to an increased energy
expenditure and contribute to weight loss.

2.3 Effects of Radiotherapy

2.3.1 Introduction

Radiotherapy is the use of high energy radiation to treat malignant
disease. Unfortunately, the area of treatment cannot be confined to the
malignant target cells and some normal tissue will be effected. If these
normal cells are in or near the gastrointestinal tract, nutritional
consequences may result from their damage during treatment. The site of
treatment is connected to the types of nutritionally related consequences
that may result. Hence, in this study, the main sites of treatment likely to
have some nutrition related consequences of radiotherapy are the head
and neck, chest and abdomino-pelvic areas of the gastrointestinal tract.

2.3.2 Head and Neck Patients

Radiotherapy to areas of the head and neck create the most nutritionally
compromising consequences of any treatment site. Localised effects of
radiotherapy to the head and neck which may result in alterations to
nutritional status are: sore throat leading to odynophagia (pain on
swallowing), dysphagia (difficult swallowing), xerostomia (dry mouth),
mucositis, anorexia (lack of appetite), hypogeusia (lack of taste) or
dysgeusia (altered taste) and nausea (Donaldson, 1977, Kokal, 1985 &
McAnena & Daly, 1986). The severity of these symptoms is related to the
dose of radiation administered and the size of the area being radiated
(Donaldson, 1977).

The impairment that occurs with a patient's taste may begin as little as
two weeks after beginning therapy (Kokal, 1985) and taste may gradually
return over one year post therapy (Donaldson, 1977). It is believed to
occur due to radiation damage of the microvilli of the taste cells or their
surfaces (Conger, 1973 cited in Donaldson, 1977). It can be appreciated
that as the sensation of taste disappears, the enjoyment of eating declines
and consequently oral intake is likely to fall.

Exposure of the salivary glands to radiation during treatment to the head
and neck may also have nutritional consequences.

Salivary excretion

decreases and the secretion becomes thick and acidic (Donaldson, 1981).
The decrease in saliva production may lead to dysphagia, especially of
dry foods. The teeth are usually protected by a coating of saliva. When
the amount of saliva produced is decreased, the teeth are more susceptible
to bacterial attack leading to dental caries (Kokal, 1985). Dysphagia and
accelerated rates of carie formation may also lead to decreased oral intake.

A simple method to observe how a patient's nutritional status is altered by
the consequences of radiotherapy to the head and neck mentioned above,
is to monitor the weight of patients throughout therapy. This technique
was used by Donaldson (1977), who found the average weight loss for 122
patients undergoing radiotherapy for cancers of the head and neck for
periods of six to eight weeks was 3.7 kg. Fourteen of the group (8.7 per
cent) lost greater than 10 per cent of their initial body weight on
completion of the therapy.

Only 10 (8.2 per cent) of the group of 122

patients remained stable or gained weight. It should be noted that these
patients received no specific dietary treatment.

Chencharick and Mossman (1983) studied 74 head and neck cancer
patients undergoing radiotherapy. They found that 94 per cent of patients
lost an average of five kilograms prior to therapy and that this weight loss
did not change throughout therapy.
these

patients

received

In contrast to Donaldson's study,

nutritional

counselling

throughout

the

radiotherapy. Also in this study a subjective questionnaire was completed
by the patients throughout the treatment addressing issues such as
occurrence of xerostomia, dysgeusia, anorexia and dysphagia.

2.3.3 Chest Patients

Radiotherapy is often used to treat patients with malignancies of the
thoracic or chest area, commonly lung or breast cancers. Common side
effects of radiotherapy to this area with possible nutritional sequelae are
oesophagitis and dysphagia. Oesophageal stricture or fistula formation
may appear as late consequences of radiotherapy (Donaldson, 1977 &
Kokal, 1985). Complaints of dysphagia are reported to appear after two or
three weeks with radiation dose levels of approximately 30 gray. The
dysphagia may last for two weeks after radiotherapy has ceased
(Donaldson, 1977).

23.4 Abdomino-pelvic Patients

Radiotherapy is often used to treat malignancies in the abdominal or
pelvic areas. Common cancer types in these areas are small or large bowel
malignancies, prostate or bladder

cancer.

The

acute effects

of

radiotherapy to the abdomino-pelvic region are nausea, vomiting and
diarrhoea (Donaldson, 1977 & Kokal, 1985). These symptoms may present
on initiation of treatment and persist throughout treatment. Clearly, over
the period of treatment these side-effects may lead to a decline in patient's
nutritional status.

Irradiation to the abdomino-pelvic area may lead to malabsorption of fat,
carbohydrate and protein, as well as electrolyte and fluid disturbances
(Kokal, 1985). Choloretic enteropathy may result from abdomino-pelvic
irradiation. Choloretic enteropathy is characterised by a malabsorption of
bile salts by the irradiated bowel, leading to malabsorption of fat and
steatorrhoea. The resulting increase in bile salts in the colon will inhibit
water absorption and stimulate colonic peristalsis, causing further fluid
and electrolyte disturbances (Kokal, 1985).

To measure alterations to nutritional status of patients undergoing
radiotherapy to the abdomino-pelvic region, Donaldson (1977) again used
weight loss as an indicator of declining nutritional status. She found that,
in a group of 67 patients undergoing whole abdominal radiotherapy for
non-Hodgkin's lymphoma over a six week period, 88 per cent of the
patients encountered weight loss and the average weight loss was 3.8 kg.
The most common radiation dose for this group was 45 Gray. Thirteen
per cent of the patients lost greater than 10 per cent of their initial body
weight.

Long term complications of radiotherapy to the abdomino-pelvic region
include intestinal obstruction, submucosal fibrosis, enteritis, colitis or
fistula formation. These complications may appear months to years after
the completion of radiotherapy and effect 0.5 to 15 per cent of patients
(Kokal, 1985).

2.4 Indicators of Nutritional Status in Oncology Patients

2Arl Introdiirtion

Because of the high likelihood of cancer patients being malnourished
before treatment or becoming malnourished due to the effects of
treatment, screening for nutritional related problems or risk of developing
these problems is necessary.

To effectively screen for these problems,

indicators of nutritional status in oncology patients must be identified.
Unfortunately, there is no one indicator of a patient's nutritional status.
Many indicators have been developed and those that have been used to
describe nutritional status in oncology patients are outlined below. The
indicators described below are all tools to help the observer, whether it be
a physician or dietitian, describe the nutritional status and likelihood of
nutrition related problems of the patient. These indicators do not replace
clinical judgment, which many observers believe to be the single most
important assessment tool (Jeejeebhoy and Meguid, 1986, Baker, Detsky,
et al., 1982 & Grant, Custer, et al., 1981). The indicators are attempts to
describe a patient's condition in an objective manner and because of
numerous methodological problems, cannot be solely relied on to assess a
patient's nutritional status.
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2,4.2 AnthropoTnetric Indicators

Of the many anthropometric measures available, body weight is the
easiest to measure, most widely used and often the most important
indicator of a patient's nutritional status.

Body weight can give an

indication of nutritional stores such as body fat and protein (Grant, Custer
et al., 1981). A patient's relative weight can be described by the Body
Mass Index (BMI):
Weight (kg)
Height2(m)
Definitions of body fatness using the BMI (NH&MRC, 1984) are:
Very underweight < 18kg/m2
Underweight

18-20kg/m2

Acceptable weight 20-25kg/m2
Overweight
Obese

25-30kg/m2
>30kg/m2

Using the BMI may give an indication of a patient's nutritional reserves
before and during treatment. In a recent study conducted by Carey (1992)
investigating the effects of radiotherapy to the head and neck and pelvic
regions it was found that prior to therapy 20% of patients had a BMI <
20kg/m2 indicating suboptimal nutrition. After treatment the number of
patients with a BMI < 20kg/m^ had not changed.

BMI cannot describe any recent weight fluctuations the patient may have
had and these may be much more important than the current weight-forheight of the patient. Weight loss may be described in a number of ways,
in kilograms or as a percentage of usual weight are two common methods.
Most studies agree that a weight loss of greater than 10% of usual body
weight is an indicator of nutrition related complications (Smith & Mullen,
1991, Zador and Truswell, 1987 & Grant, Custer et al., 1981).

Subcutaneous fat stores can be assessed using skinfold calipers and can
accurately reflect total body fat stores.

However, large variance in

measurements taken between three different observers has been noted
using this method and to be considered abnormal it is suggested that
measurements be below the fifth percentile of normal (Jeejeebhoy and
Meguid, 1986). Baker and colleagues (1982) found that clinical judgment
was a better predictor of patient's outcome than triceps skinfold.

The anthropometric indicators of skeletal muscle mass commonly used in
oncology patients are mid-arm circumference (MAC) and mid-arm muscle
circumference (MAMC). The MAMC is derived from a formula which
includes triceps skinfold and MAC.

MAC is measured with a tape

measure and compared to tables of "normal" to determine the percentile
of normal. This leads to two sources of error, first the error involved with
attaining the measurement, secondly the error arising when comparing a
single measurement to a sample of a population classified as "normal".
Because of these errors patients can only be described as having an
abnormal MAC if the measurement is less than the fifth percentile of
normal.

In Carey's study (1992) it was found that after 6 weeks of radiotherapy to
the head and neck or pelvic regions the mean decrease in MAMC was
0,384mm. To be able to detect a true change in arm muscle circumference
calculated from MAC and triceps skinfolds. Hall and colleagues (1980)
thought the change needed to be at least 2.68cm. Similarly, Macia and
colleagues (1991) found that a group of head and neck cancer patients
who underwent radiotherapy with an average dose of 61 Gray had a
decrease in MAMC of only 1cm over the period of treatment, with no
dietary intervention.

2,43 Biochemical Indicators

The most common biochemical indicators used in studies to describe the
nutritional status of cancer patients are the serum proteins, albumin and
transferrin. Both of these proteins are synthesised in the liver and the
assumption is that depressed serum concentrations of the proteins is due
to decreased biosynthesis by the liver as a result of lack of substrate
associated with malnutrition (Grant, Custer, et al., 1981). In large
population studies decreased albumin concentrations are associated with
decreased dietary protein intakes.

Gray and Meguid conducted a study in 1990 investigating 22 patients
with cancer, who had initial serum albumin concentrations of

<35g/L

(normal 40-52g/L), who had been administered total parenteral nutrition
(TPN) solutions providing an average of 197% of their predicted basal
energy requirements and 1.54g/kg of protein per day for 21 days. Serum
albumin and body weight were measured before and after the 21 days of
TPN. Body weight over the 21 days increased from an average of 51kg to
54kg, however serum albumin fell from 30.8g/L to 28.6g/L. Gray and
Meguid concluded that low serum albumin in cancer patients is not
reflective of their nutritional status, but is a consequence of the disease
itself.

Carey's study (1992) found no significant difference in patient's serum
albumin or transferrin levels before and after six weeks of radiotherapy to
the head and neck and pelvic areas with dietary counselling available.
Macia et al. (1991) found a significant decrease in serum albumin and
transferrin concentrations of patients undergoing radiotherapy to the head
and neck after treatment with no dietary intervention but no difference in
those that did receive dietary counselling throughout treatment.

With

patients receiving abdomino-pelvic irradiation, however, no significant
difference was found in serum albumin or transferrin levels after
treatment in both the group who received dietary counselling and those
who did not.

2,4.4 Clinica] Tndiratorft

As mentioned above, many authors feel that clinical judgment is the most
important assessment tool and may be more accurate at predicting
complications than objective measurements (Baker et al., 1982). Clinical
indicators of nutritional status are signs or symptoms that may present as
a result of poor nutritional status or signs or symptoms of conditions that
are likely to lead to a decline in the nutritional status of the patient. In
cancer patients we know that these conditions may occur as a result of the
disease itself or as a consequence of treatment. These indicators have been
investigated in cancer patients usually by either objective examination by
physicians or subjective questionnaires completed by the patient.

Macia and colleagues (1991) had two doctors assess symptoms and signs
in their study group of 93 oncology patients undergoing radiotherapy.
They reported the presence of

dysphagia, odinophagia, anorexia,

diarrhoea, decreased oral intake, mucositis and radiodermatitis in patients
undergoing radiotherapy to the head and neck, breast or abdomino-pelvic
regions. They found 12 per cent and 43 per cent of head and neck patients
suffered worsening

dysphagia

and odinophagia respectively with

treatment, whilst none of the breast or abdomino-pelvic group had any
worsening dysphagia or odinophagia. In the head and neck, breast and
abdomino-pelvic groups, 61 per cent, 21 per cent and 59 per cent
respectively suffered worsening anorexia.

Fifty nine per cent of the

abdomino-pelvic group suffered worsening diarrhoea. These results were
from the control group who received no dietary counselling or
intervention.

Nayel and colleagues (1992) studied clinical indicators in head and neck
cancer patients undergoing radiotherapy by subjective questionnaire
dealing with xerostomia, dysgeusia, hypogeusia, dysphagia, anorexia and
food preferences. The questionnaire was completed before the start of
radiotherapy and at weekly intervals for six weeks during therapy. After
four weeks (40 Gy) of therapy 91 per cent of patients complained of a dry
mouth. Before radiotherapy 17 per cent of patients were aware of taste
changes and a lack of appetite, after five weeks (50 Gy), 70 per cent were
aware of these problems. Twenty two per cent of patients were aware of
swallowing difficulties before therapy, after therapy 82 per cent
complained of dysphagia.

There was no significant difference in the

number of complications patients were subjectively aware of between the
group who received no oral nutritional supplementation and the group
which did receive supplementation.

Chencharick and Mossman (1983) also used a subjective questionnaire in
head and neck radiotherapy patients to assess changes in clinical
indicators of nutritional status with radiotherapy. They found 25 per cent
of patients complained of dry mouth before radiotherapy and this number
increased to 80 per cent by the fourth week of treatment. Fourteen per
cent of patients reported taste changes before, by the fifth week 84 per
cent complained of dysgeusia. Anorexia incidence increased from 20 per
cent before therapy to 60 per cent after the fourth week of therapy.

2.4.5 Diptary Indicators

A declining nutritional status may be due to a decrease in the intake of
energy or protein over a period of time. There are many tools available to
describe a person's daily oral intake. These measurement tools usually
depend on the subject's ability to recall intake or accurately record intake.
Very few studies have attempted to accurately describe the usual daily
oral intake of oncology patients. Those that have, relied on the 24 hour
recall method of describing oral intake.

Chencharick and Mossman (1983) took 24 hour dietary histories from
eight patients after one week of radiotherapy and after six weeks of
therapy. They found that early in therapy, patient's average daily energy
intake was 7300 kilojoules. Late in therapy this had decreased to 7100
kilojoules per day. The average protein intake at week one was 72g per
day, whilst after six weeks of therapy it was 66g per day.

Carey's 1992 study on head and neck and pelvic radiotherapy patients had
24 hour dietary recalls taken from each patient at weekly intervals for six
weeks. Protein intake fell from 74g per day in the first week of therapy to
64g per day in the last week. The estimated protein requirement for the
group was 86g per day.

Average daily energy intake fell from 7610

kilojoules to 5710 kilojoules over the six weeks of treatment. The average
daily energy requirement for these patients was calculated to be 10,150
kilojoules. This requirement was obtained from a 1979 paper by Long et
al. who estimated requirements using indirect calorimetry and nitrogen
balance. The requirements were not developed for cancer patients
specifically. As already mentioned, cancer effects the host's metabolism in
ways not fully understood and no daily energy or protein requirements
have been specified for cancer patients at this time.

2.5 Use of Alternative Treatments in Oncology Patients

A study by Feigen and Tiver (1992) at Westmead Hospital showed that in
a group of 202 cancer patients 27 per cent had used unconventional
dietary supplements, consulted alternative health practitioners or both.
Another 24 per cent of the group were using minor dietary modifications
or low dose vitamin supplementation.

Of those using major dietary

supplements the most common types were high doses of vitamins, usually
A, B, C and E and herbal extracts, mostly in the form of herbal tea. The
most popular types of alternative practitioners were naturopaths, faith
healers and meditation group leaders.

The study found no consistent trend between the use of alternative and
the type of conventional treatment received, the site or stage of their
cancers, the patient's prognosis or the clinical course of the disease.
Feigen

and

Tiver

(1992)

report

that

although

there

is

strong

epidemiological evidence that diet may be a factor in the aetiology of
cancer, there is little evidence that changing diet after cancer has
developed will change the course of the disease.

Excessive doses of

vitamins or other supplements may be toxic, may interfere with
conventional treatment and confound diagnostic tests. To my knowledge
there has been no study of this type conducted with cancer patients
receiving radiotherapy.

2.6 Selection of Diet Survey Methods

To describe oral intake before and after radiotherapy, a 24 hour dietary
recall was used.

This was the preferred method of decribing patient's

intakes in similar studies by Carey (1992) and Chencharick and Mossman
(1983). The method was chosen primarily because of the speed and ease
with which the survey could be completed.

A study by Gersovitz,

Madden and Wright (1978) showed that for a group of elderly subjects the
24 hour recall gave a relatively valid estimate of their mean daily intake.

There are several limitations with the use of the 24 hour recall method. It
has been found that the method tends to overestimate low intakes and
underestimate high intakes. There is also a danger

of false negatives

(failing to detect an actual difference between groups) when comparing
dietary intakes of groups of people

(Gersovitz, Madden, et al. (1978).

Beaton and colleagues (1979) concluded that the precision of the estimate
of an individual's usual intake based on one 24 hour recall, is relatively
low. However if the focus of attention is on the mean intake of a group, as
in this study, the low precision may not be as important as it is with
observations of a single subject.

2.7 Conclusion

It is reasonably well established that patients presenting for radiotherapy
for treatment of cancers of the gastrointestinal tract, especially those with
head and neck cancers may have compromised nutritional status before
beginning treatment. Radiotherapy to regions of the gastrointestinal tract
can produce side effects that are likely to have an negative effect on the
cancer patients's nutritional status. The aim of this study is to investigate
the changes in nutritional status in patients undergoing radiotherapy by
observing the changes in anthropometric, clinical and dietary indicators of
nutritional status.

Chapter 3

Method

Chapter 3
Method

Ethics

Ethics approval was sought and granted by the University of Wollongong
Human Experimentation Ethics Committee under Category 1.2: Collecting
individually unidentifiable data by survey from informed consenting
adults.

No ethics approval was sought from St George Hospital after

consultation with the Director of the CCC. It was felt that the study did
not impede on the subjects enough to warrant attaining approval.

All

patients were fully informed and gave written consent to their
participation in the study (refer appendix 1).

Subjects

The population for this study consisted of 45 consecutive patients that
presented for radiotherapy planning at the St George Hospital CCC over a
six week period. During the study two patients died. Three patients were
missed when completing the final questionnaire due to sickness of the
researcher.

A total of 40 patients completed both initial and final

questionnaires. One patient was excluded from the study because they
were receiving radiotherapy to both head and neck and chest region.
Fifty nine per cent (23) of the population were male, 41 per cent (16) were
female. The population was divided into four main categories depending
on the site of their treatment. There were three Head and Neck (HN)
patients (8 per cent), 17 Abdomino-pelvic (AP) patients (43 per cent), 14
Chest (C) patients (36 per cent) and five Other (O) patients (13 per cent).
Only two patients initially approached refused to take part in the study.

Research Dp^ign

Subjects were approached when they presented for radiotherapy planning
and asked if they would participate in the study. After completing the
consent form (see appendix 1), the sole researcher read the questions on
the initial questionnaire (see appendix 2) to the patient and recorded the
answers on the questionnaire. This avoided any ambiguity with questions
as the researcher was on hand to explain any questions which the patients
found difficult.

The questionnaire had been pilot tested on a small group

of patients before the study was commenced and minor changes were
made to its structure. After the questionnaire was completed, a 24 hour
dietary recall with checklist was conducted, again with the researcher
recording the patient's intake on an answer sheet (see appendix 3). The
patient's height and weight were measured and recorded.

The initial

consult took between 10 to 15 minutes.

Treatment usually commenced two to three days after the planning
session. Subjects were seen again on or about their last day of treatment,
usually four to six weeks after treatment commenced. On this occasion
they were again weighed and asked to answer the second questionnaire
(see appendix 4), which was read out by the researcher who also recorded
the answers. A second 24 hour dietary recall was conducted and the
results recorded by the researcher. The final consult took between five
and ten minutes. At this stage patient contact ceased.

It should be noted that approximately nine final consultations were
conducted by telephone the week after the patients had finished their
treatment, due to the researcher becoming ill. Patient's weights on or
about their last day of treatment were obtained from nursing notes.
Questions on the questionnaire as well as the 24 hour recall appeared to
be understood and answered appropriately over the telephone by
patients.

Data Analysis

The results of the 24 hour dietary recall were analysed using the "Diet 1"
(NutTab 1992 database) Dietary Analysis Package.

Daily intakes of

energy (kj) and protein (g) were analysed and recorded. Statistical tests
were used to determine if there were any differences between the four
study group's demographics (including age, initial BMI and amount of
radiation received) weight loss, energy and protein intake and symptoms
following radiotherapy.

The statistics were analysed using the JMP

statistics package. All tests were carried out using parametric analysis of
variance, where the distribution of scores were thought to be not normal,
a non-parametric Wilcoxin-Signed Rank test was used.
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Description of Study Groups

HN*

AP

c

O

Total

Number

3

17

14

5

39

Male

2

16

3

2

23

Female

1

1

11

3

16

Age

57

69

58

51

61

Initial BMI

31

28

27

26

27

Gray

43

51

45

37

46

Prior Treatment

2

11

10

5

28

HN = Head and Neck, AP = Abdomino-pelvic, C = Chest, O = Other.

Table 4.1. Description of Study Groups.

Table 4.1 shows the number of patients in each study group, the
distribution of gender, the group's average age, average BMI and average
amount of radiation absorbed during treatment and the number from each
group who had either surgery, chemotherapy, radiotherapy or some
combination of the three before presenting for radiotherapy.

From Table 4.1 we can see that the HN and O groups contain very small
numbers and hence conclusions from results of these groups will be very
difficult to make.

The AP group is dominated by males usually with

rectal or prostate cancer.

The C group contains a majority of females

usually with breast cancer (See appendix 5 for full breakdown of cancer
sites among the study groups).

The AP group appears to be older on average than the other groups,
however. Analysis of Variation showed no significant difference between
ages in all groups (F Ratio=2.35, Prob>F=0.09) (Prob>F must be <0.05 to be
significant). There was also no significant difference between the initial
BMIs of the groups (F Ratio=0.83, Prob>F=0.49). It was interesting to see
that the average BMI of the groups before therapy exceeded the
recommended level of 20-25kg/m2 and classified in the overweight range.
Only two patients had a BMI of less than 20kg/m2 (i.e underweight), they
were both females from the Chest group. The average radiation (Gray)
absorbed by the patients in the groups over their periods of treatment
was also not significantly different (F Ratio=2.53, Prob>F=0.07).
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Figure 4.1. Weight Fluctuations Before and During Treatment.

Figure 4.1 shows the weight fluctuations before treatment and during
treatment of the four study groups as well as the study population as a
whole.

Subjects were asked what their weight was prior to being

diagnosed with cancer in the initial questionnaire. From this weight was
subtracted the weight obtained by the researcher at the initial consult to
give the weight fluctuation before treatment. From Figure 4.1 it is obvious
that the HN group had lost by far the most weight before treatment.
Overall, the AP group had actually put on an average of one kilogram
from the pre-diagnosis weight they gave.

The C and O groups and the

group as a whole had no fluctuation in weight before therapy.

During their treatment the group as a whole lost an average of 0.4kg. On
average, the AP group lost 0.7kg, the C group lost 0.3kg, the HN group
had the largest weight fluctuation of -1.7kg and the O group actually put
on 1.1kg overall over their course of treatment. In order to see if there was
any difference in weight due to treatment, an analysis of variance with
weight before treatment was carried out.

No significant difference in

weight fluctuations during treatment was found between each group (F
Ratio=2.2, Prob>F=0.087).
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Figure 4.2 Weight Loss Before and During Treatment

Figure 4.2 shows the number of patients in eac±i group who had weight
loss before and during treatment and the average amount of weight loss
in each study group.

Before treatment, three (100 per cent) of the HN

group had lost an average of 6.7kg. Seven (41 per cent) and six (43 per
cent) patients in the AP and C groups had lost an average of 3.0kg and
2.6kg respectively before treatment. During treatment the HN group had
the largest weight loss with two (67 per cent) of the subjects losing an
average of 2.5kg each. The AP group had the next largest weight loss
with eight (47 per cent) of the patients losing 2.3kg each. Seven of the C
group lost an average of 1.4kg each during treatment. Three (60 per cent)
of the O group had lost 3.4kg before treatment, however none of the O
group lost any weight during treatment.

Reported Sidp Fffprtc; of Trpafmpnt

Appendix 6 contains full analysis of the side effects reported by the HN,
AP and C groups before and after treatment. The Other group was not
included in these analyses because side effects reported by this group
cannot be attributed to the effects of radiation on the gastrointestinal tract.

Two side effects were found to be significantly different between groups.
The first was diarrhoea where 13 patients (76 per cent) in the AP group
complained of diarrhoea after treatment. This was significantly higher
than any other group (F Ratio=10.52, Prob>F=0.00). The other reported
side effect of significance was dysphagia. Before treatment none of the C
group had reported dysphagia. After treatment, seven of the C group (50
per cent) reported dysphagia which was significantly higher than the
other groups, except the HN group (F Ratio=4.95, Prob>F=0.01).

Supplement Use

Patients were asked if they were using any dietary supplement at the time
of treatment. Supplements commonly used were vitamins, usually B or
C, herbs such as garlic or herbal tea.

Three patients were drinking

Sustagen or a similar high protein, high energy supplement. Overall 18 of
the group (46 per cent) were using some dietary supplement.

Study Group

No. Using Siipplpmpnt (Perceni-agp of Grmip)

Head and Neck

0/3

(0 per cent)

Chest

9/14

(64 per cent)

Abdomino-pelvic

6/17

(35 per cent)

Other

3/5

(60 per cent)

Table 4.2 Supplement Use Among Study Groups.

Table 4.2 shows the use of dietary supplements among the study groups
during treatment. From Table 4.2 we can see that the Chest group has the
greater percentage of patients using some dietary supplement. Compared
to the abdomino-pelvic group, these patients were typically younger,
female and tended to be more liberal in their use of vitamin and herbal
supplements.

Energy and Protein Fluctuations with Treatment.

HNi

AE

C

Q

Initial Energy
Intake (kj/d)

7250

8600

6200

6300

Final Energy
Intake (kJ/d)

6950

8000

6050

5800

Difference (kJ/d)

-300

-600

-150

-500

HN = Head and Neck, AP = Abdomino-pelvic, C = Chest, O = Other.

Figure 4.3 Energy Fluctuations with Treatment.

Figure 4.3 shows the average daily energy intake of the four study groups
before beginning radiotherapy, after radiotherapy had ceased and the
difference between the two intakes. All groups consumed less energy
after treatment had ceased than before radiotherapy commenced,
however, none of these decreases in intake were statistically significant (F
Ratio=0.35, Prob>F=0.79).

Although there are no specific daily dietary requirements set for oncology
patients, it is interesting to compare the above results, especially of the AP
and C groups, to the Australian Recommended Daily Intakes (RDI) for
men over 64 years (the bulk of the AP group) and women over 54 years
(the majority of the C group) as described by the National Health and
Medical Research Council. The RDI of energy for men over 64 years is
10,600 kj and for women over 54 years, 8,000 kj. Both the AP and the C
group consumed less energy than the RDI before and after treatment.

UN*

AE

c

a

Initial Protein
Intake (g/d)

63

90

62

68

Final Protein
Intake (g/d)

72

79

62

66

Difference (g/d)

9

-11

0

-2

*HN = Head and Neck, AP = Abdomino-pelvic, C = Chest, O = Other.

Table 4.4 Protein Fluctuations with Treatment.

Figure 4.4 shows the average daily amount of protein consumed by each
group before treatment, after treatment and the difference between the
two. Compared to the RDI of protein for men over 64 years of 55g per day
and for women over 54 years of 45g per day, the AP and C group are
consuming more protein than is deemed necessary by the NH&MRC. The
differences between the protein intakes before and after treatment in all
study groups are very small.
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Anthropomeirir indicators

If

nutritional status was measured using the Body Mass Index (BMI)

alone, this sample of radiotherapy patients would be classified as having
good nutritional status due to oz^^rconsumption, not necessarily what one
would expect in a group of people with cancer. The mean BMI for the
study population was 27kg/m2, thus, the study population appears to
have large nutritional reserves. This result falls between results in two
other similar studies. Macia and colleagues (1991) found abdomino-pelvic
and breast groups had an average BMI of SOkg/m^ before treatment. The
1992 study by Carey, found the average BMI of her study population,
made up of 20 head and neck and pelvic radiotherapy patients, was
24kg/m^ before treatment.

Only two out of the 39 patients (5 per cent) in this study had a BMI less
than 20kg/m2 i.e. were classified as underweight. In contrast, four of 20
patients (20 per cent) in Carey's study had a BMI of less than 20kg/m2
when starting treatment. There is obviously some difference between the
two populations.

Probably the main difference is that, this study

investigated all patients presenting for radiotherapy, not only those
receiving treatment for HN or AP cancers.

As a group, the population of this study had no decrease in weight prior
to their diagnoses with cancer until the time they started treatment. Thus,
on average, their weight had been stable for some time. After treatment,
the group had lost an average of 0.4kg. Nineteen of the study population
(49 per cent) had lost weight before treatment, with the average loss being
3.5kg. During treatment, 17 of the group (44 per cent) lost weight with the
average loss being 2.0kg.

Donaldson (1977) found 92 per cent of 122 HN patients lost an average of
3.7 kg during six to eight weeks of radiotherapy.

Chencharick and

Mossman (1983) found that their group of 74 HN patients had an average
weight loss of 5 kg before treatment and this weight loss did not change
during treatment. It is difficult to compare these results to this study
where 67 per cent of the group (2 patients) lost an average of 6.7kg before
and 2.5kg during treatment due to the very small size of the HN group.

The result in the AP group compares more closely with Donaldson's
study, where the 88 per cent of the AP group lost an average of 3.8kg
compared to 47 per cent per cent of the AP group losing 2.3kg in this
study.

Had numbers in the groups been closer, there were 67 in

Donaldson's study, 17 in this study, the results may have been in more
agreeance.

Donaldsons's study was conducted in 1979 (and is still the most
comprehensive of its type), and no patient received any dietary
intervention. At the St George Cancer Care Centre nutrition advice is now
an integral part of the patient's care and this, along with improved
methods of treatment may lead to less weight loss in radiotherapy
patients now than over a decade ago.

If we now took weight loss as the sole indicator of nutritional status, then
this study population appears to have had good nutritional status before
radiotherapy and this c±ianged little with therapy. Certainly no patient
lost greater than ten per cent of their body weight, the level at which most
authors agree (Smith & Mullen, 1991, Zador and Truswell, 1987 & Grant,
Custer et al., 1981) demands dietary intervention, during therapy and
only two had lost greater than ten per cent (10.4 and 11.8 per cent) before
treatment, however this was based on the patient's recall of their weight
before diagnosis of cancer.

Clinical Indicators

There is substantial evidence

that patients experience

significant

nutritional problems as a result of cancer and that radiotherapy and other
cancer

treatments

may

exacerbate

these

problems.

Subjective

questionnaires have been used to identify these problems in HN patients
undergoing radiotherapy (Nayel et al., 1992, Chencharick and Mossman,
1983).

A subjective questionnaire was used in this study to identify

changes in these clinical indicators of nutritional status.

Very few comparisons can be made between the results of the subjective
reports of side effects of the HN group in this and the two studies
mentioned above because of the small number of patients in the HN
group. If the group was larger, however, we would expect the HN group
to complain of side effects in a manner that reflects the findings of the
studies done in this area. That is, we would expect a percentage of the
subjects to have swallowing difficulties, anorexia and some taste changes
before therapy, and these percentages would increase markedly with
treatment. Xerostomia, which may not be present before radiotherapy
would probably effect 80 to 90 per cent of patients at some time during
treatment (Nayel et al., 1992, Chencharick and Mossman, 1983).

Macia and colleagues (1991) found that in a group of abdomino-pelvic
patients undergoing radiotherapy, 59 per cent had worsening anorexia, 59
per cent had worsening diarrhoea and there were no complaints of
dysphagia during treatment. The results of this study compare well with
Macia's findings in that the number of patients in the AP group
complaining of diarrhoea increased from two before treatment to 13 after
treatment, therefore 65 per cent of the group had worsening diarrhoea.
There were also no complaints of dysphagia before or after treatment in
the AP group and none were expected given the area in which the
radiation was absorbed.

Complaints of anorexia did rise from three

before treatment to five after but this was not reflective of the increase in
lack of appetite that Macia found. This was perhaps due to the fact that
none of the group in Macia's study received any dietary intervention and
six of the AP group in this study had been referred to the oncology
dietitian during the course of their treatment.

The most significant clinical indicator of nutritional status that appeared
during treatment in the C group was dysphagia.

In Macia's study, a

group of breast cancer patients had no complaints of dysphagia during
radiotherapy.

Dysphagia is not necessarily expected in breast cancer

patients as the field that is irradiated does not usually include the
oesophagus. In the C group in this study, which was 64 per cent breast
cancer patients,

seven (50 per cent) of the patients complained of

dysphagia after treatment, with no dysphagia reported before treatment.
Of the nine breast cancer patients in the group, two (22 per cent) reported
dysphagia after treatment.

It would be interesting to have a larger population of breast cancer
patients to see if this trend is consistent. If it is, questions would have to
be raised about the placement of treatment fields in the breast cancer
patients, as we would not anticipate 22 per cent of the women with breast
cancer undergoing radiotherapy to develop dysphagia.

Of the HN, AP and C study groups, it appears that the HN group is likely
to suffer the greatest decline in nutritional status due to clinical factors
such as anorexia, xerostomia, dysphagia and dysgeusia however the
results of this study, because of the small numbers in the HN group
cannot be used to add weight to this argument.

Patients receiving radiotherapy to the abdomino-pelvic area are likely to
develop diarrhoea during treatment. This was shown in this study and
adds weight to the arguments in the literature. Diarrhoea in these patients
may be an indicator of declining nutritional status as malabsorption of fat
and other nutrients is likely to occur (Kokal, 1985).

Patients receiving radiation to the c±iest area, especially those with lung
cancer, are likely to develop dysphagia during treatment as a result of the
proximity of the treatment field to the oesophagus and the consequent
effect of radiation on the mucosa of the oesophagus (Donaldson, 1977).
This was supported by this study and it was also found that two of nine
breast cancer patients developed dysphagia with treatment. This was not
expected, as the treatment field in breast cancer would not be expected to
include any part of the oesophagus.

Dysphagia has an obvious

detrimental effect on nutritional status by limiting patient's food intake.

Dietary Indicators

The energy and protein fluctuations seen in this study from before
treatment to after treatment, although indicating a downward trend, were
not significant. Carey (1992) found the average daily energy and protein
intake in a group of HN and AP patients before radiotherapy was 7600kJ
and 74g respectively. This compares closely with the results from this
study where the average daily energy and protein intakes for the study
population as a whole before treatment were 7350kJ and 75g respectively.
Both studies used the 24 hour dietary recall method to obtain these results.

There are no dietary requirements established for cancer patients at this
time but when compared to the Australian RDIs the patients in this study
were consuming significantly less energy than recommended. Usually,
this would mean that the population would be losing weight due to poor
energy intake. However it was found that this population had stable
weight for some time prior to treatment. This apparent contradiction is
probably best explained by the data collection method, i.e. the 24 hour
dietary recall, not accurately describing the individual's usual intake. It
may also be due to the effects of cancer on the metabolism of the host
which are not fully understood at this time.

If a declirung oral intake is indicative of a declining nutritional status in
cancer patients, then one would have to say that radiotherapy had little
effect on the intake and hence the nutritional status of the patients in this
study using the 24 hour recall method to describe intake.

Supplement Use

Use of supplements may or may not effect the nutritional status of a
cancer patient. However, it is helpful for nutrition professionals to know
the incidence of supplement use among cancer patients. In this study,
patients in the C group were the biggest users of supplements which were
commonly doses of

the "antioxidant" vitamins, A,C and E, or herbal

preparations such as teas or garlic tablets.
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The nutritional status of a cancer patient is effected by many things. In
this study anthropometric, clinical and dietary indicators of nutritional
status were used to try and determine if radiotherapy made any
difference to the nutritional status of the patient, or if nutritional status
differed between groups of patients receiving radiotherapy to different
regions of the gastrointestinal tract. This study found that anthropometric
and dietary indicators of nutritional status did not indicate poor
nutritional status in this group of subjects and did not change significantly
with treatment. The results of this study show that clinical indicators of
nutritional status that were subjectively reported by patients after
treatment had ceased, were most important in detecting possible declines
in nutritional status.

The significant difference between the two largest study groups in these
clinical indicators was that abdomino-pelvic patients are likely to develop
diarrhoea during treatment and patients undergoing radiotherapy to the
chest area are likely to develop dysphagia during treatment.

Both

dysphagia and diarrhoea may lead to declines in nutritional status.
Patients receiving radiotherapy to the head and neck area are likely to
develop numerous clinical indicators of declining nutritional status
during treatment, however, due to the small number of subjects in this
group of tiie study, no weight can be added to the argument present in the
literature.

Recommendations

Future research in this area should take into consideration a number of
recommendations. Firstly, strive for as large a population size as possible.
Whilst the AP and C groups in this study had just sufficient numbers to
draw meaningful results from, the HN group certainly did not. This was
disappointing as most of the research in this area had been done using
head and neck cancer patients.

The use of a 24 hour dietary recall to obtain usual daily intakes of patients,
whilst quick and easy to carry out, should be discouraged. I believe a
three day food record would be significantly more accurate and may
produce a result that does show a significant difference in intakes before
and after treatment.

Try to evaluate as many indicators of nutritional status as possible. The
major omissions from this study were biochemical measures such as
serum proteins. The more indicators that are evaluated, the clearer the
overall picture one will obtain of the actual nutritional status of the
patient.

Limitations of the Study

1.

Small sample size in some study groups such as the HN and O

groups made it difficult to draw meaningful results from these groups
and impossible to compare them with other studies.

2.

Use of 24 hour dietary recall to estimate energy and protein intakes

before and after treatment.

Use of a three day food record may have

yielded a much more accurate result.

3.

No food models were used during the 24 hour recall to more

accurately judge the actual amounts of food consumed.

4.

No biochemical indicators of nutritional status such as serum

albumin or transferrin were used in this study because they were not
routinely obtainable from the patients in this setting.

5.

Data entry errors. When entering food intake data into the Diet 1

software package, various assumptions had to be made when full details
of a particular food were not given.
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Appendix 1

CONSENT FORM

NUTRITION STUDY IN ONCOLOGY PATIENTS
This research is being conducted as part of a Master of Science (Nutrition and Dietetics)
degree at the University of WoUongong under the supervision of Ms J McArthur. The
aim of the study is to determine how an oncology patient's nutritional status is altered
after undergoing radiotherapy.
I agree to participate in this study. I understand that it requires a survey to be completed,
my height and weight to be measured and a dietary record to be taken.
Participation or non participation will not effect the treatment that I receive now or in the
future. If at any time I wish to cease participation I understand that I am able to do so.
Any enquiries regarding conduct of research may be forwarded to:
The Secretary
University of WoUongong
Human Experimentation Ethics Committee
Telephone: (042) 213079

Signature
Date:
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MRN.

NUTRITIONAL STATUS SURVEY (1)
Have you ever had any of the following treatments for cancer?
Radiotherapy

•

Chemotherapy

•

Surgery

•

Other

•

No

Please Describe
•

Have you ever seen a dietitian before?
No
Yes

n
•

When?
Why

Have you ever sought or been given dietary advice from anyone other than a dietitian (eg
Doctor, Naturopath, books, etc)?
No
Yes

n
•

Doctor

•

Wt. Loss Centre

•

Naturopath

•

Friend

•

Books

n

Other

•

Would you describe your appetite now as:

Good

•

Fair

•

Poor

•

Since being diagnosed with cancer, has your appetite been:
Remaining Stable

•

Increasing

•

Decreasing

•

Are there any foods which you find difficult to eat in any of the following food groups?
Fruit & Vegetables

•

Meat & Meat Products

•

Breads & Cereals

•

Fats & Oils

•

Milk & Dairy Products

•

No

•

Other

n

In which of the following food groups have you detected any taste changes?
Fruit & Vegetables

•

Meat & Meat Products

•

Breads & Cereals

•

Fats & Oils

•

Milk & Dairy Products

•

No

•

Other

n

Are there any particular foods or food groups you avoid in your diet?
Fruit & Vegetables

•

Meat & Meat Products

•

Breads & Cereals

•

Fats & Oils

•

Milk & Dairy Products

•

No

•

Other

•

Have you used any methods to change the consistency of any of your foods?
Mincing

•

Thickening

Pureeing

n

Mashing

Juicing

•

No

Other

n

•
•
•

Are you taking any regular dietary supplements?

Herb Preps

•
•
•
•

Sustagen

n

No
Vitamins
Minerals

Skim Milk Powder
Canned Supplements
Amino Acids
Others

•
a
a
•

Since being diagnosed with cancer:
Do you have any feelings of nausea?
Never
Sometimes
Often
Alwa}^

•

•
•
•

To what extent does this
interfere with the enjoyment
of your life?

0
1

10
1 1 1 1 i 1

Not at all

1 I
Intense Interference

Do you have any episodes of vomiting?
Never

D

Sometimes

•

Often

•

Mways

a

0
Not at all

10
Intense Interference

Do you have any episodes of diarrhoea?
Never

•

Sometimes

•

Often

•

Always

•

0
i

I

I

Not at all

10

I

Intense Interference

Do you have any episodes of constipation?
Never

•

Sometimes O
Often

•

Always

G

0

i

I

I

10

I

Not at all

Intense Interference

Do you have any difRculty swallowing foods?
Never

•

Sometimes O
Often

•

Always

D

10

0

Intense Interference

Not at all

Do you have feelings of a diy mouth?
Never

•

Sometimes D
Often

•

0

Always

•

Not at all

10
I

l_l
Intense Interference

Do you experience a lack of appetite?
Never

C3

Sometimes

•

Often

•

Always

a

10

0
I—I—I
Not at all

_l—l_l—I
Intense Interference

Appendix 3

MRN.
24 HOUR DIETARY RECALL (1)
BREAKFAST

MORNING TEA

LUNCH

AFTERNOON TEA

TEA

SUPPER

CHECKLIST
A.
B.
C.
D.
E.
F.

Red meat. White meat. Milk. Cheese. Eggs. Fish. Legumes.
Free Vegetables, Fruit - Fresh, Dried. Juice.
Potato/Rice/Pasta, Bread, Cereals, Biscuits, Cakes.
Butter/Margarine, Cream, Oil, Salad Dressings.
Chocolates, Lollies, Icecream, Desserts.
Drinks - Alcohol, Soft drinks. Cordial, Water, Tea, Coffee

Activity Level?.

Appendix

4

MRN.

NUTRITIONAL STATUS SURVEY (2)
Would you describe your appetite now as:
Good

•

Fair

•

Poor

n

Since commencing radiotherapy,

has your appetite been:
Remaining Stable

•

Increasing

•

Decreasing

O

Are there any foods which you find difficult to eat in any of the following food groups?
Fruit & Vegetables

•

Meat & Meat Products

•

Breads & Cereals

•

Fats & Oils

•

Milk & Daily Products

•

No

d

Other

•

In which of the following food groups have you detected any taste changes?
Fruit & Vegetables

•

Meat & Meat Products

•

Breads & Cereals

•

Fats & Oils

•

Milk & Daily Products

•

No

Other

CJ

O

Are there any particular foods or food groups you avoid in your diet?
Fruit & Vegetables

•

Meat & Meat Products

•

Breads & Cereals

•

Fats & Oils

•

Milk & Daily Products

•

No

•

Other

n

Have you used any methods to change the consistency of any of your foods?
Mincing

•

Thickening

•

Pureeing

•

Mashing

•

Juicing

•

No

a

Other

•

Are you taking any regular dietary supplements?
No
Vitamins
Minerals
Herb Preps
Sustagen

•
•
•
•
•

Skim Milk Powder
Canned Supplements
Amino Acids
Others

•
•
•
•

Do you have any feelings of nausea?
Never

•

To what extent does this
interfere with the enjoyment
of your life?

Sometimes O
Often
Alwajrs

•
•

0

I I I !
Not at all

10

Intense Interference

Do you have any episodes of vomiting?
Never

O

Sometimes D
Often
Always

n
•

0
Not at all

10
Intense Interference

Do you have any episodes of diarrhoea?
Never

•

Sometimes

•

Often

n

Always

O

0
Not at all

10
Intense Interference

Do you have any episodes of constipation?
Never

D

Sometimes n
Often

•

0

Always

•

Not at all

10
Intense Interference

Do you have any difficulty swallowing foods?
Never

•

Sometimes

•

Often

•

Always

G

To what extent does this
interfere with the enjoyment
of your life?

0

I

I

I

i

10

I

Not at all

Intense Interference

Do you have feelings of a dry mouth?
Never

G

Sometimes O
Often

•

0

Always

•

Not at all

10
Intense Interference

Do you experience a lack of appetite?
Never

O

Sometimes O
Often

•

Always

D

0
Not at all

10
i

I

I I
Intense Interference

Appendix 5

Distribution by Cancer Site.
Breast

Rectum

Tonsil 1
Sigmoid 1
Minimantle 1
Femur 1
Endometrium 1
Chest Wall 1
Bladder 1
Back 1
Arm/Hip 1
Abdomen 1

8

Prostate

5
Lung

Total Patients = 39

8

4

Groin
Brain 2

2

Appendix 6

Nausea

Head & Neck (3)

Chest (14)

Abdomino-pelvic (17)

Study Group (No. in Group)
M Before Treatment •

After Treatment

Diarrhoea

Head & Neck (3)

Chest (14)

Abdomino-pelvic (17)

Study Group (No. in Group)
H Before Treatment •

After Treatment

Dysphagia

Head & Neck (3)

Chest (14)

Abdomino-pelvic (17)

Study Group (No. in Group)
M Before Treatment •

After Treatment

Anorexia

Head & Neck (3)

Chest (14)

Abdomino-pelvic (17)

Study Group (No. in Group)
H Before Treatment •

After Treatment

Xerostomia

Head and Neck (3)

Chest (14)

Abdomino-pelvic (17)

Study Group (No. in Group)
0

Before Treatment •

After Treatment

Taste Changes with Therapy

0
Head & Neck (3)

Chest (14)

Abdomino-pelvic (17)

Study Group (No. in Group)
M

Before

Treatment •

After Treatment

Food Avoidance with Therapy

Head & Neck (3)

Chest (14)

Abdomino-pelvic (17)

Study Group (No. in Group)
i l Before Treatment •

After Treatment
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